Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell-cycle inhibitor profiling by high-content analysis.

Advances in experimental medicine and biology - 1 Jan 2007

Gasparri Fabio, Ciavolella Antonella, Galvani Arturo

Abstract excerpt

The discovery of agents which disrupt cancer cell division by specifically targeting key components of the cell-cycle machinery represents a major focus of recent drug discovery efforts in Oncology. The drug discovery process can be greatly enhanced by multiparametric cellular analysis which can assist in confirmation, often in a few multiplexed assays, of the mechanism of action (MOA) of compounds identified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle
Share to DNA, Complementary
Share to DNA Damage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Drug Screening Assays, Antitumor

Share to Histones

Share to Microscopy, Fluorescence

Share to Oligonucleotide Array Sequence Analysis

Source

Identifiers

PMID: 17695726
DOI: 10.1007/978-0-387-69116-9_13

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell-cycle inhibitor profiling by high-content analysis.PMID 17695726Read ↗

Highly multiplexed phenotypic imaging for cell proliferation studies.Semantic proximity Read ↗

A robust high-content imaging approach for probing the mechanism of action and phenotypic outcomes of cell-cycle modulators.Semantic proximity Read ↗

Multidimensional Profiling of Drug-Treated Cells by Imaging Mass CytometrySemantic proximity Read ↗

High-content assays in oncology drug discovery: opportunities and challenges.Semantic proximity Read ↗

Systematic characterization of cell cycle phase-dependent protein dynamics and pathway activities by high-content microscopy-assisted cell cycle phenotyping.Semantic proximity Read ↗

A Scalable 3D High-Content Imaging Protocol for Measuring a Drug Induced DNA Damage Response Using Immunofluorescent Sub-nuclear γH2AX Spots in Patient Derived Ovarian Cancer OrganoidsSemantic proximity Read ↗

A Scalable 3D High-Content Imaging Protocol for Measuring a Drug Induced DNA Damage Response Using Immunofluorescent Subnuclear γH2AX Spots in Patient Derived Ovarian Cancer OrganoidsSemantic proximity Read ↗

High-content phenotypic profiling of drug response signatures across distinct cancer cells.Semantic proximity Read ↗

Quality Control Measures and Statistical Strategies to Address the Challenges of High-Content Phenotypic Data.Semantic proximity Read ↗

A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cellsSemantic proximity Read ↗

Large-scale cytological profiling for functional analysis of bioactive compounds.Semantic proximity Read ↗

Linking phenotypes and modes of action through high-content screen fingerprints.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.